Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 733 to 782 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
733\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fzr1 protein; fizzy-related protein; cdc20-like 1b. [source:refseq;acc:nm\_016263]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
13241.4\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
11864\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.1161\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
734\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proprotein convertase subtilisin/kexin type 5 precursor (ec 3.4.21.-) (proprotein convertase pc5) (subtilisin/kexin-like protease pc5) (convertase pc5) (pc6) (hpc6). [source:swissprot;acc:q92824]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
735\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase 16 kda proteolipid subunit (ec 3.6.3.14). [source:swissprot;acc:p27449]\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5768.32\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6434.78\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.11554\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
736\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sarcoglycan zeta; zeta-sarcoglycan. [source:refseq;acc:nm\_139167]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
737\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
golgi complex associated protein 1; golgi resident protein gcp60; peripherial benzodiazepine receptor associated protein; golgi phosphoprotein 1; pbr associated protein; pka (rialpha)-associated protein. [source:refseq;acc:nm\_022735]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
738\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
delta-sarcoglycan (sg-delta) (35 kda dystrophin-associated glycoprotein) (35dag). [source:swissprot;acc:q92629]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
739\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cellular modulator of immune recognition. [source:refseq;acc:nm\_145021]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
740\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase 21 kda proteolipid subunit (ec 3.6.3.14) (hatpl). [source:swissprot;acc:q99437]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
741\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-sarcoglycan (gamma-sg) (35 kda dystrophin-associated glycoprotein) (35dag). [source:swissprot;acc:q13326]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
742\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 3 subunit 4 (eif-3 delta) (eif3 p44) (eif-3 rna-binding subunit) (eif3 p42) (eif3g). [source:swissprot;acc:o75821]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4131.04\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4607.9\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.11543\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
743\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 3 subunit 10 (eif-3 theta) (eif3 p167) (eif3 p180) (eif3 p185) (eif3a). [source:swissprot;acc:q14152]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
744\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytidine triphosphate synthase ii; ctp synthetase type 2; utp-ammonia ligase; ctp synthetase isoform; cytidine 5'-triphosphate synthetase 2. [source:refseq;acc:nm\_019857]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12515.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11221.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11535\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
745\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuroepithelial cell transforming gene 1; guanine nucleotide regulatory protein (oncogene); rho guanine nucleotide exchange factor (gef) 8. [source:refseq;acc:nm\_005863]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4086.6\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4557.68\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.11527\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
746\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rho guanine nucleotide exchange factor 3; rhogef protein; 59.8 kda protein; exchange factor found in platelets and leukemic and neuronal tissues, xpln. [source:refseq;acc:nm\_019555]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
747\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
down-regulated in metastasis. [source:refseq;acc:nm\_014503]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
748\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ctp synthase (ec 6.3.4.2) (utp--ammonia ligase) (ctp synthetase). [source:swissprot;acc:p17812]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12503.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11212\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11517\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
749\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ethanolamine-phosphate cytidylyltransferase (ec 2.7.7.14) (phosphorylethanolamine transferase) (ctp:phosphoethanolamine cytidylyltransferase). [source:swissprot;acc:q99447]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4565.34\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5085.92\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.11403\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
750\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin light chain 1, skeletal muscle isoform (mlc1f) (a1 catalytic) (alkali). [source:swissprot;acc:p05976]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
751\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin light chain 1, slow-twitch muscle b/ventricular isoform (mlc1sb) (alkali). [source:swissprot;acc:p08590]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
752\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 13 kda-a subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-13kd-a) (ci-13kd-a). [source:swissprot;acc:o75380]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
753\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin light chain 1, slow-twitch muscle a isoform (mlc1sa) (alkali). [source:swissprot;acc:p14649]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
754\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin light chain 1, embryonic muscle/atrial isoform (pro1957). [source:swissprot;acc:p12829]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
755\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar rna-associated protein alpha isoform. [source:refseq;acc:nm\_022917]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4079.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4545.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11402\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
756\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
topoisomerase-related function protein 4-2. [source:refseq;acc:nm\_022447]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4725.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5261.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11339\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
757\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
signal recognition particle 68 kda protein (srp68). [source:swissprot;acc:q9uhb9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5622.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6260.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11331\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
758\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna polymerase epsilon subunit b (ec 2.7.7.7) (dna polymerase ii subunit b). [source:swissprot;acc:p56282]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3760.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4185.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11316\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
759\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
6-phosphofructokinase, type c (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme c) (pfk-c) (6-phosphofructokinase, platelet type). [source:swissprot;acc:q01813]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4254.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4736.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11315\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
760\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atpase, h+ transporting, lysosomal 38kda, v0 subunit d isoform 2. [source:refseq;acc:nm\_152565]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5870.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11298\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
761\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor if-2. [source:swissprot;acc:o60841]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5811.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6467.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1129\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
762\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pms1 protein homolog 2 (dna mismatch repair protein pms2). [source:swissprot;acc:p54278]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6231.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6933.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11275\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
763\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
6-phosphofructokinase, muscle type (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme a) (pfk-a) (phosphofructokinase-m). [source:swissprot;acc:p08237]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4250.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4729.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11272\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
764\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
6-phosphofructokinase, liver type (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme b) (pfk-b). [source:swissprot;acc:p17858]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4250.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4729.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11269\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
765\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polymerase (dna directed) sigma; topoisomerase-related function protein 4-1; polymerase (dna-directed) sigma. [source:refseq;acc:nm\_006999]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4726.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5258.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11268\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
766\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 variant 1 isoform b; dna-binding protein. [source:refseq;acc:nm\_003349]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6691.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7445.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11255\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
767\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
utp--glucose-1-phosphate uridylyltransferase 2 (ec 2.7.7.9) (udp- glucose pyrophosphorylase 2) (udpgp 2) (ugpase 2). [source:swissprot;acc:q16851]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6691.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7444.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11254\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
768\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 variant 2; 1 alpha,25-dihydroxyvitamin d3-inducible; enterocyte differentiation promoting factor; methyl methanesulfonate sensitive 2, s. cerevisiae, homolog of. [source:refseq;acc:nm\_003350]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6690.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7443.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11253\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
769\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit f (ec 3.6.3.14) (v-atpase f subunit) (vacuolar proton pump f subunit) (v-atpase 14 kda subunit). [source:swissprot;acc:q16864]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5873.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6532.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11214\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
770\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit g 2 (ec 3.6.3.14) (v-atpase g subunit 2) (vacuolar proton pump g subunit 2) (v-atpase 13 kda subunit 2). [source:swissprot;acc:o95670]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5874.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6533.34\vspace{3pt}}}&\multirow{13}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.11211\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
771\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
apoptosis inhibitor 5; fibroblast growth factor 2-interacting factor 2; api5-like 1. [source:refseq;acc:nm\_006595]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
772\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sec13-related protein. [source:swissprot;acc:p55735]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
773\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit g 3 (ec 3.6.3.14) (v-atpase g subunit 3) (vacuolar proton pump g subunit 3) (v-atpase 13 kda subunit 3). [source:swissprot;acc:q96lb4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.34\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
774\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
yeast sec31p homolog. [source:refseq;acc:nm\_014933]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
775\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit g 1 (ec 3.6.3.14) (v-atpase g subunit 1) (vacuolar proton pump g subunit 1) (v-atpase 13 kda subunit 1) (vacuolar atp synthase subunit m16). [source:swissprot;acc:o75348]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.33\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
776\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ganglioside-induced differentiation-associated protein 1-like 1. [source:refseq;acc:nm\_024034]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
777\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead (asp-glu-ala-asp) box polypeptide 39 isoform 1; nuclear rna helicase, decd variant of dead box family. [source:refseq;acc:nm\_005804]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.34\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
778\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit b, kidney isoform (ec 3.6.3.14) (v- atpase b1 subunit) (vacuolar proton pump b isoform 1) (endomembrane proton pump 58 kda subunit). [source:swissprot;acc:p15313]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.23\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
779\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ganglioside-induced differentiation-associated protein 1. [source:refseq;acc:nm\_018972]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5874.76\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
780\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit d (ec 3.6.3.14) (v-atpase d subunit) (vacuolar proton pump d subunit) (v-atpase 28 kda accessory protein). [source:swissprot;acc:q9y5k8]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
781\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
secretory pathway component sec31b-1. [source:refseq;acc:nm\_015490]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
782\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit h (ec 3.6.3.14) (v-atpase h subunit) (vacuolar proton pump h subunit) (v-atpase 50/57 kda subunits) (vacuolar proton pump subunit sfd) (cgi-11). [source:swissprot;acc:q9ui12]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6533.33\vspace{3pt}}&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/